Biodesix, Inc. (BDSX)

NASDAQ: BDSX · IEX Real-Time Price · USD
3.81
-0.43 (-10.14%)
At close: Jan 21, 2022 4:00 PM
3.83
0.02 (0.52%)
After-hours:Jan 21, 2022 5:56 PM EST

Total Valuation

Biodesix has a market cap or net worth of $117.29 million. The enterprise value is $99.37 million.

Market Cap117.29M
Enterprise Value99.37M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Biodesix has 30.78 million shares outstanding. The number of shares has increased by 10,026.71% in one year.

Shares Outstanding30.78M
Shares Change (YoY)+10,026.71%
Shares Change (QoQ)+1.16%
Owned by Insiders (%)80.13%
Owned by Institutions (%)15.82%
Float6.59M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio1.58
PB Ratio7.32
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Sales1.34
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 2.48, with a Debt / Equity ratio of 1.87.

Current Ratio2.48
Quick Ratio2.22
Debt / Equity1.87
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -115.30%, which is considered low. The company has a ROIC of -96.20%.

Return on Equity (ROE)-115.30%
Return on Assets (ROA)-32.10%
Return on Capital (ROIC)-96.20%
Revenue Per Employee$371,555
Profits Per Employee-$172,050
Employee Count200
Asset Turnover0.69
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -86.09% in the last 52 weeks.

Beta (1Y)n/a
52-Week Price Change-86.09%
50-Day Moving Average4.87
200-Day Moving Average7.61
Average Volume (30 Days)162,001

Short Selling Information

Short Interest422,445
Short % of Shares Out1.37%
Short % of Float6.41%
Short Ratio (days to cover)1.54

Income Statement

In the last 12 months, Biodesix had revenue of $74.31 million and -34.41 million in losses. Earnings per share was -$1.36.

Revenue74.31M
Gross Profit31.63M
Operating Income-30.43M
Net Income-34.41M
EBITDA-27.64M
EBIT-30.69M
Earnings Per Share (EPS)-$1.36
Full Income Statement

Balance Sheet

The company has $47.91 million in cash and $30.00 million in debt, giving a net cash position of $17.92 million or $0.58 per share.

Cash & Cash Equivalents47.91M
Total Debt30.00M
Net Cash17.92M
Net Cash Per Share$0.58
Book Value16.03M
Book Value Per Share0.52
Working Capital33.66M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.78 million and capital expenditures -$2.45 million, giving a free cash flow of -$29.23 million.

Operating Cash Flow-26.78M
Capital Expenditures-2.45M
Free Cash Flow-29.23M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross margin is 42.57%, with operating and profit margins of -40.95% and -46.31%.

Gross Margin42.57%
Operating Margin-40.95%
Pretax Marginn/a
Profit Margin-46.31%
EBITDA Margin-37.20%
EBIT Margin-41.30%
FCF Margin-39.34%

Dividends & Yields

Biodesix does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-29.34%
FCF Yield-24.92%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a